Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminotadalafil is a **synthetic small-molecule structural analog of tadalafil** that acts as a **phosphodiesterase type 5 inhibitor**. It is not an approved medicine and is primarily known as a **research and analytical reference compound** used in structure-activity relationship work examining how amino substitution on the tadalafil scaffold affects PDE5 binding, selectivity, and related physicochemical or metabolic properties. Aminotadalafil has also been reported as an **illicit adulterant** in products marketed for erectile dysfunction or sexual enhancement, but it has **no legitimate approved human or veterinary therapeutic use** and is sold only for research purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aminotadalafil.